MW 525.6 Da, Purity >98%. Potent, irreversible PI3-kinase inhibitor. Inhibits purified phosphoinositide (PtdIns)-3-kinase (IC50 = 0.1 nM) and PtdIns-3-kinase signaling as assessed by phospho-Ser473-Akt levels in HT-29 colon cancer cells (IC50 = 20 nM). Ring-opened analog of wortmannin (ab120148). Displays antitumor activity.
View Alternative Names
5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha, 5-bisphosphate 3-kinase catalytic subunit alpha isoform, CLOVE, CWS5, FK506 binding protein 12 rapamycin associated protein 1, FK506 binding protein 12 rapamycin associated protein 2, FK506-binding protein 12-rapamycin complex-associated protein 1, FKBP rapamycin associated protein, FKBP12-rapamycin complex-associated protein, FKBP12-rapamycin complex-associated protein 1, FLJ44809, FRAP, FRAP1, FRAP2, KAPCG_HUMAN, KAPG, MCAP, MCM, MCMTC, MGC142161, MGC142163, MTOR_HUMAN, Mammalian target of rapamycin, Mechanistic target of rapamycin, OTTHUMP00000001983, PI 3 Kinase catalytic subunit alpha, PI3 kinase p110 subunit alpha, PI3-kinase subunit alpha, PI3K, PI3K-alpha, PI3KC A, PIK3C A, PK3CA_HUMAN, PKA C-gamma, PKACg, PRKACG, Phosphatidylinositol 3 kinase catalytic alpha polypeptide, Phosphatidylinositol 3 kinase catalytic 110 KD alpha, Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha, Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha isoform, Phosphatidylinositol 4,5 bisphosphate 3 kinase 110 kDa catalytic subunit alpha, Phosphatidylinositol-4, Phosphoinositide 3 kinase catalytic alpha polypeptide, Protein kinase cAMP dependent catalytic gamma, PtdIns 3 kinase p110, PtdIns-3-kinase subunit alpha, PtdIns-3-kinase subunit p110-alpha, RAFT1, RAPT1, Rapamycin and FKBP12 target 1, Rapamycin associated protein FRAP2, Rapamycin target protein, Rapamycin target protein 1, Serine (threonine) protein kinase, Serine/threonine protein kinase PIK3CA, Serine/threonine-protein kinase mTOR, cAMP-dependent protein kinase catalytic subunit gamma, caPI3K, dJ576K7.1 (FK506 binding protein 12 rapamycin associated protein 1), p110 alpha
- Chemical Structure
Lab
Chemical Structure - PX-866, PI3-kinase inhibitor (AB142172)
2D chemical structure image of ab142172, PX-866, PI3-kinase inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MTOR regulates the cell cycle cell growth and protein synthesis by integrating signals from nutrients and energy status. Within the cell mTORC1 and mTORC2 belong to separate biochemical complexes that are regulating a range of functions. PI3 kinase activity of PIK3CA facilitates the activation of mTORC1 by generating phosphatidylinositol-345-trisphosphate (PIP3) important for subsequent protein activation steps. PRKACG engages in signaling pathways promoting cellular responses through cyclic adenosine monophosphate (cAMP). Together these components orchestrate cellular metabolic demands with extracellular growth signals.
Pathways
These proteins participate prominently in the PI3K/AKT/mTOR signaling pathway critical for cellular proliferation and survival. This pathway includes a sequence beginning with PI3 kinase's conversion of phosphatidylinositol to PIP3 leading to AKT activation. The pathway concludes with mTOR activation further regulating ribosomal protein S6 kinase and eukaryotic initiation factor 4E-binding protein. Another related pathway is the cAMP signaling pathway where PRKACG contributes through protein kinase A-mediated activation mechanisms. These pathways are engaged with proteins like AKT as well as ribosomal proteins indicating intricate interdependencies.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com